Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Recbio Technology Co Ltd | 0.00 | -614.43m | 3.99bn | 472.00 | -- | 3.44 | -- | -- | -1.28 | -1.28 | 0.00 | 2.40 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -267.86m | 4.51bn | 133.00 | -- | 4.12 | -- | -- | -1.34 | -1.34 | 0.00 | 5.42 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 664.03m | -128.24m | 4.63bn | 813.00 | -- | 3.27 | -- | 6.98 | -0.2518 | -0.2518 | 1.30 | 2.78 | 0.2732 | 1.35 | 2.53 | 816,760.10 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Ocumension Therapeutics | 264.66m | -407.99m | 4.64bn | 444.00 | -- | 1.47 | -- | 17.53 | -0.6288 | -0.6288 | 0.4077 | 4.54 | 0.078 | 3.61 | 2.12 | 596,081.30 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Consun Pharmaceutical Group Ltd | 2.78bn | 842.79m | 4.91bn | 3.13k | 5.53 | 1.21 | 5.29 | 1.77 | 1.05 | 1.05 | 3.48 | 4.80 | 0.4981 | 2.08 | 10.05 | 889,809.60 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.00bn | -58.03m | 5.03bn | 2.87k | -- | 1.06 | -- | 2.52 | -0.0062 | -0.0062 | 0.215 | 0.5103 | 0.1572 | 0.8101 | 4.72 | 695,921.50 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 869.32m | 109.78m | 5.38bn | 948.00 | 16.12 | 0.7033 | -- | 6.19 | 0.1067 | 0.1067 | 0.8256 | 2.45 | 0.2852 | 1.44 | 1.62 | 917,003.60 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Everest Medicines Ltd | 135.28m | -907.17m | 6.23bn | 432.00 | -- | 1.15 | -- | 46.05 | -2.90 | -2.90 | 0.4321 | 16.71 | 0.0203 | 2.25 | 4.57 | 313,154.20 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.28bn | 634.01m | 6.52bn | 4.10k | 10.28 | 0.8809 | 4.78 | 0.8959 | 0.495 | 0.495 | 5.68 | 5.78 | 0.5212 | 0.9835 | 5.68 | 1,774,299.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| China Shineway Pharmaceutical Group Ltd | 4.85bn | 1.04bn | 6.89bn | 3.44k | 6.04 | 0.9116 | 5.65 | 1.42 | 1.38 | 1.38 | 6.42 | 9.14 | 0.5073 | 1.44 | 6.31 | 1,412,077.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 7.48bn | 798.00 | 13.83 | 1.93 | 11.11 | 4.90 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Cansino Biologics Inc | 370.81m | -1.59bn | 7.51bn | 1.49k | -- | 0.8624 | -- | 20.26 | -6.45 | -6.45 | 1.50 | 22.94 | 0.0332 | 2.37 | 0.4619 | 248,201.00 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.76bn | 2.14bn | 7.88bn | 4.62k | 3.68 | 0.9249 | 3.27 | 1.17 | 2.43 | 2.43 | 7.68 | 9.69 | 0.5111 | 3.62 | 4.09 | 1,464,263.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 8.26bn | 1.62k | -- | 2.11 | -- | 6.47 | -1.15 | -1.15 | 1.05 | 3.23 | -- | -- | -- | 785,492.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.60bn | 572.15m | 10.61bn | 5.27k | 18.45 | 0.788 | 7.96 | 1.61 | 0.1529 | 0.1529 | 1.77 | 3.58 | 0.247 | 2.42 | 3.60 | 1,252,222.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Data as of Jul 05 2024. Currency figures normalised to CanSino Biologics Inc's reporting currency: Hong Kong Dollar HKD
10.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 06 Jun 2024 | 3.25m | 2.45% |
| BlackRock Fund Advisorsas of 29 Nov 2022 | 2.88m | 2.17% |
| DSM Capital Partners LLCas of 31 Mar 2023 | 1.38m | 1.04% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.28m | 0.96% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 944.00k | 0.71% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 893.52k | 0.67% |
| BlackRock Advisors (UK) Ltd.as of 29 Nov 2022 | 879.00k | 0.66% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 724.00k | 0.55% |
| BlackRock (Netherlands) BVas of 29 Nov 2022 | 678.69k | 0.51% |
| BlackRock Japan Co. Ltd.as of 29 Nov 2022 | 541.22k | 0.41% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
